HomeNewsIndiaCoronavirus state-wise tally November 24: Delhi's COVID-19 count rises to 5.3 lakh, death toll at 8,512

Coronavirus state-wise tally November 24: Delhi's COVID-19 count rises to 5.3 lakh, death toll at 8,512

With more than 17.8 lakh COVID-19 cases, Maharashtra has reported the highest number of infections, followed by Karnataka (8.74 lakh) and Andhra Pradesh (8.62 lakh).

November 24, 2020 / 10:45 IST
Story continues below Advertisement
Representative image
Representative image

Delhi recorded 4,454 fresh COVID-19 cases on November 23 while 121 more fatalities pushed the death toll to 8,512. This is the sixth time in the last 12 days that the daily number of deaths has crossed the 100-mark.

The active cases tally stood at 37,329. The bulletin said that the total number of cases has climbed to 5,34,317 of which 4,88,476 have recovered.

Story continues below Advertisement

With over 17.8 lakh cases, Maharashtra's COVID-19 tally remains the highest among Indian states and union territories, according to the Union Health Ministry's latest update.

Follow our LIVE blog for updates on the COVID-19 pandemic

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show